Although the tumor classification is robust with respect to aGCT, i.e. all contain the FOXL2 C134W mutation, the designation of stage could potentially be problematic in that a stage 1 aGCT could, for instance, be an advanced tumor caught early. The gene discussed is FOXL2; the disease is neoplasm.